Visualize, explore, and customize your kinome profiling results with our NEW Kinome Tree Mapping Application!
Kinase & Phosphatase Assays Reinvented
Get real-time, kinetic data that translates to clinical impact.
Leveraging simpler assays to deliver richer data
Characterizing targets and assessing compound potency, selectivity, and mechanism of action are critical steps in disease research and drug development, especially with the expanding focus on kinase inhibitors.
Developed by MIT scientists, PhosphoSens® technology provides a direct, continuous measure of enzyme activity that captures the complete reaction under physiologically relevant conditions—enabling better decisions regarding target biology and generation of lead candidates to empower faster movement through the drug discovery process.
Publications
Patents
Enzyme targets
Of the top pharma companies use PhosphoSens
Technology |
Single step process |
Direct measurement of phosphorylation |
Real-time/Continuous measurement |
Mimics physiological conditions |
Amenable to complex samples |
Cost per test |
Enzyme-Coupled Assay Systems | ||||||
---|---|---|---|---|---|---|
Radiometric Assay Systems | ||||||
Antibody-Based Assay Systems | ||||||
Mobility Shift Assay Systems | ||||||
PhosphoSens | * |
Real-time, kinetic assays in our lab or yours
Don’t see what you’re looking for?
Resources and Data from AssayQuant scientists and partners
Sox-based Sensor Phosphopeptides for Continuous, Homogeneous, and Quantitative Monitoring of Protein Phosphatase Activity
Protein phosphatases are critical drug targets for cancer therapy development with a need for robust assays that monitor phosphatase enzyme activity. Learn how our assays continuously monitor protein phosphatase activity.
Automated Linear Range Determination and Applications to Enzymatic Progress Curves
When interrogating protein kinases and their inhibitors, a continuous assay format allows you to confidently visualize and quantify enzyme activity across the entire progress curve. Learn about our fully automated protocol to streamline and optimize linear range finding in our latest scientific poster.
The Advantages of Kinome Profiling With a Continuous Assay
Join Earl May, Ph.D., Sr. Director of Discovery Technologies, as he delves into the unique advantages of continuous assays over their endpoint counterparts, reveals hidden insights within raw data, and demonstrates how progress curves can help you identify essential aspects of an inhibitor's mode of action.
Development of a Real-Time, Fluorescence Microplate Assay for Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Activity
Epidermal Growth Factor Receptor (EGFR) wild-type and mutant tyrosine kinase activity and the downstream signaling cascades are pivotal in oncogenesis, drug resistance, and tumor recurrence. Learn how our team developed a continuous, real-time, fluorescence-based assay for EGFR tyrosine kinase inhibitors (TKI’s).